A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
NCT00382408
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
4040
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Tract Diseases
Interventions
BIOLOGICAL:
DR-5001
OTHER:
Placebo
Sponsor
Duramed Research